UNION STEM CELL & GENE ENGINEERING CO., LTD. (USCGEN) was registered in Tianjin Huayuan Hi-tech Park in 2001, with a registration capital of one hundred million RMB and on the basis of technical support from Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College. The USCGEN includes a Hematopoietic Stem Cell Bank, an Antibody Department and a Tianjin Union Hospital. The USCGEN is committed to the cryopreservation and clinical application of stem cells,R&D, manufacture and distribution of monoclonal antibodies and gene chips .
The Tianjin cord blood stem cell bank established by USCGEN is one of the largest stem cell banks in the world. It is the first approved cord blood stem cell bank in China by both of Ministry of Health, People’s Republic of China, and AsiaCord, with a preservation capacity of 300 thousand cord blood units. Since April 2001, Tianjin cord blood stem cell bank has searched thousands cord blood units for local and foreigner clients.
The Antibody Department was established on the basis of technical advantage from the Institute of Hematology, Chinese Academy of Medical Sciences, which has more than 20 years of experience in monoclonal antibody research and development. We have developed more than 60 anti-human monoclonal antibodies clustered by Human leukocyte differentiation antigen (HLDA) workshop with different specificities, and have developed a number of monoclonal antibodies and related kits for flow cytometry. The R&D project “Production of conjugated monoclonal antibody in large scale” was approved by the Ministry of Science and Technology of the People’s Republic of China in 2004. ”The Classification Kit for Anti Erythrocyte Surface IgG\IgM\IgA\C3” was approved by SFDA (State Food and Drug Administration), as well as national key innovational products.
Stem Cell project is a demonstration project of National Industrial Base of Stem Cell Technology supported by National Development and Reform Commission, as well as key Hi-tech Industrial Project by Tianjin government in 2005.
Actually, more than 300 staffs work in USCGEN, 95% of them graduated from the university, and 30% hold master and/or doctor degree. Many of them have been trained in the leading universities in the world, or worked as senior manager and researchers in famous companies. The USCGEN has established a post-doctoral workstation in 2001.
Tianjin Cord Blood Stem Cell Bank Processing Center has approximately 1000 square meter with 10,000 grade and 100 grade highly clean areas. Enclosed the clean area under GMP program (Good Manufacturing Practice).
Brief Introduction
